Replies to post #23103 on Cytodyn Inc (CYDY)

[trding]

So I'm guessing around July 10th

July 12th last patient finished missed it by 2 days :)


Some notes as I heard them--could be not exact


FDA reduced safely numbers to 150 patients.

303 patients enrolled in mono, but trial remains open

40% of 350mg dose responded, non-responders switched to 525 dose.
70% of 525mg dose responded!!!!!

Even higher dose 1 a week injection at 700mg is going to be tested

100% of patients that stopped Pro 140 were able to return to HAART without issues.

Going to meet with FDA to discuss switching to Pivotal Mono Trial